Tenofovir to prevent perinatal transmission of Hepatitis B

New England Journal of Medicine

Volumn 378, Issue 24, 2018, Pages 2348-2349

  Terrault, Norah A ^a   Feld, Jordan J ^b   Lok, Anna S F ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; TENOFOVIR DISOPROXIL; VIRUS DNA; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; TENOFOVIR;

ANTIVIRAL THERAPY; GLOBAL DISEASE BURDEN; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LETTER; PREGNANT WOMAN; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; TIME TO TREATMENT; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; CHRONIC HEPATITIS B; FEMALE; GENETICS; HEPATITIS B VIRUS; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL;

ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TENOFOVIR;

EID: 85049139320     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1805396     Document Type: Letter

References (5)

1. Global hepatitis report: executive summary. Geneva: World Health Organization, 2017.
2. Jourdain G, Ngo-Giang-Huong N, Harrison L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med 2018; 378: 911-23.
3. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560-99.
4. Brown RS Jr, McMahon BJ, Lok AS, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 2016; 63: 319-33.
5. Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016; 374: 2324-34.